| Dr Vivek Sahai, MD | |
|
4605 Sawmill Rd, Upper Arlington, OH 43220-2246 | |
| (614) 827-8700 | |
| (614) 827-8701 |
| Full Name | Dr Vivek Sahai |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 19 Years |
| Location | 4605 Sawmill Rd, Upper Arlington, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609076934 | NPI | - | NPPES |
| 0054270 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 35097798 (Ohio) | Secondary |
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 35.097798 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth Home Health | Worthington, OH | Home health agency |
| Riverside Methodist Hospital | Columbus, OH | Hospital |
| Ohio State University State Health System | Columbus, OH | Hospital |
| Memorial Hospital | Marysville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic One, Inc. | 3072598283 | 253 |
News Archive
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
Geron Corporation today announced positive data on its orally available small molecule telomerase activator, TAT153, in an animal model of idiopathic pulmonary fibrosis (IPF). The data show that administration of TAT153 increased telomerase activity in the lung tissue, reduced inflammation, preserved functional lung tissue, slowed disease progression and attenuated loss of pulmonary function.
A study involving nearly 27,000 older adults on five continents found that nearly 1 in 10 met criteria for pre-dementia based on a simple test that measures how fast people walk and whether they have cognitive complaints.
› Verified 1 days ago
| Entity Name | Orthopedic One, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548289697 PECOS PAC ID: 3072598283 Enrollment ID: O20040622000841 |
News Archive
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
Geron Corporation today announced positive data on its orally available small molecule telomerase activator, TAT153, in an animal model of idiopathic pulmonary fibrosis (IPF). The data show that administration of TAT153 increased telomerase activity in the lung tissue, reduced inflammation, preserved functional lung tissue, slowed disease progression and attenuated loss of pulmonary function.
A study involving nearly 27,000 older adults on five continents found that nearly 1 in 10 met criteria for pre-dementia based on a simple test that measures how fast people walk and whether they have cognitive complaints.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vivek Sahai, MD 4605 Sawmill Rd, Upper Arlington, OH 43220-2246 Ph: (614) 827-8700 | Dr Vivek Sahai, MD 4605 Sawmill Rd, Upper Arlington, OH 43220-2246 Ph: (614) 827-8700 |
News Archive
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
Geron Corporation today announced positive data on its orally available small molecule telomerase activator, TAT153, in an animal model of idiopathic pulmonary fibrosis (IPF). The data show that administration of TAT153 increased telomerase activity in the lung tissue, reduced inflammation, preserved functional lung tissue, slowed disease progression and attenuated loss of pulmonary function.
A study involving nearly 27,000 older adults on five continents found that nearly 1 in 10 met criteria for pre-dementia based on a simple test that measures how fast people walk and whether they have cognitive complaints.
› Verified 1 days ago
Marlo Van Steyn, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Dr. Joseph Mileti, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Dr. Peter H Edwards Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Thomas James Ellis, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Scott Elwin Van Aman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Corey Lee Vanhoff, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 | |
Dr. Louis J Unverferth, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4605 Sawmill Rd, Upper Arlington, OH 43220 Phone: 614-827-8700 Fax: 614-827-8701 |